HIGHLIGHTS
- who: Sonia Vibhakar and colleagues from the Clinics, Kansas City, USA have published the research: Ethambutol Induced Optic Neuritis Associated with Tenofovir Nephrotoxicity, in the Journal: (JOURNAL)
- what: Tenofovir is one of the agents classified as preferred by the Department of Health and Human Services (DHHS) HIV treatment guidelines and ethambutol is the first line agent for MAC treatment but requires weight based dosing and dose adjustments in the presence of renal dysfunction.
SUMMARY
Of note, her weight which had increased by 3 kg had now decreased by 5 kg ~ 48 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.